Literature DB >> 19644130

Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan.

Hiroaki Ishiko, Koki Aoki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19644130      PMCID： PMC2725644          DOI： 10.1128/JCM.r00313-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  17 in total

1.  new type of APC virus from epidemic keratoconjunctivitis.

Authors:  E JAWETZ; S KIMURA; A N NICHOLAS; P THYGESON; L HANNA
Journal:  Science       Date:  1955-12-16       Impact factor: 47.728

2.  An outbreak of epidemic keratoconjunctivitis caused by a new intermediate adenovirus 22/H8 identified by molecular typing.

Authors:  Ilka Engelmann; Ijad Madisch; Heidi Pommer; Albert Heim
Journal:  Clin Infect Dis       Date:  2006-08-24       Impact factor: 9.079

3.  Restriction site mapping of adenovirus type 8 genome types.

Authors:  T Adrian; U Wolf; H J Lauer; R Wigand
Journal:  Res Virol       Date:  1990 Nov-Dec

Review 4.  [Studies on exogenous and endogenous factors associated with various ocular diseases].

Authors:  Shigeaki Ohno
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2005-12

5.  Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis--a double-blind, randomized, phase-2 clinical trial.

Authors:  Barbara Teuchner; Markus Nagl; Axel Schidlbauer; Hiroaki Ishiko; Ernst Dragosits; Hanno Ulmer; Koki Aoki; Shigeaki Ohno; Nobuhisa Mizuki; Waldemar Gottardi; Clara Larcher
Journal:  J Ocul Pharmacol Ther       Date:  2005-04       Impact factor: 2.671

6.  Molecular epidemiology of adenoviral conjunctivitis in Hanoi, Vietnam.

Authors:  Xue-Hai Jin; Hiroaki Ishiko; Thanh Ha Nguyen; Takeshi Ohguchi; Masataka Akanuma; Koki Aoki; Shigeaki Ohno
Journal:  Am J Ophthalmol       Date:  2006-09-05       Impact factor: 5.258

7.  Five new genome types of adenovirus type 37 caused epidemic keratoconjunctivitis in Sapporo, Japan, for more than 10 years.

Authors:  Toshihide Ariga; Yasushi Shimada; Kenji Shiratori; Kazuhiro Ohgami; Shudo Yamazaki; Yoshitsugu Tagawa; Masayuki Kikuchi; Yoshie Miyakita; Kozo Fujita; Hiroaki Ishiko; Koki Aoki; Shigeaki Ohno
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

8.  Clinical and aetiological study of adenoviral conjunctivitis, with special reference to adenovirus types 4 and 19 infections.

Authors:  K Aoki; M Kato; H Ohtsuka; K Ishii; N Nakazono; H Sawada
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

9.  Intermediate human adenovirus type 22/H10,19,37 as a new etiological agent of conjunctivitis.

Authors:  M Noda; Y Miyamoto; Y Ikeda; T Matsuishi; T Ogino
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

Review 10.  A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.

Authors:  Koki Aoki; Yoshitugu Tagawa
Journal:  Int Ophthalmol Clin       Date:  2002
View more
  33 in total

1.  Comparison of in-house real-time quantitative PCR to the Adenovirus R-Gene kit for determination of adenovirus load in clinical samples.

Authors:  Hélène Jeulin; Alexandra Salmon; Pierre Bordigoni; Véronique Venard
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

2.  Simian adenovirus type 35 has a recombinant genome comprising human and simian adenovirus sequences, which predicts its potential emergence as a human respiratory pathogen.

Authors:  Shoaleh Dehghan; Jason Seto; Morris S Jones; David W Dyer; James Chodosh; Donald Seto
Journal:  Virology       Date:  2013-10-08       Impact factor: 3.616

3.  Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen.

Authors:  Michael P Walsh; Jason Seto; Morris S Jones; James Chodosh; Wenbo Xu; Donald Seto
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

4.  Serotype determination of adenoviruses in children with respiratory infection.

Authors:  Yusuf Ghasemi; Manoochehr Makvandi; Ali Reza Samarbafzadeh; Ahmad Nejati; Saeed Najafifard; Niloofar Neisi; Mojtaba Rasti; Kambiz Ahmadi; Ahmad Shamsizadeh; Roya Nikfar
Journal:  Indian J Pediatr       Date:  2014-02-14       Impact factor: 1.967

5.  Computational analysis of human adenovirus serotype 18.

Authors:  Michael P Walsh; Jason Seto; Damaris Tirado; James Chodosh; David Schnurr; Donald Seto; Morris S Jones
Journal:  Virology       Date:  2010-06-09       Impact factor: 3.616

Review 6.  Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?

Authors:  Gargi Dasgupta; Lbachir BenMohamed
Journal:  Vaccine       Date:  2011-06-28       Impact factor: 3.641

7.  Complete genome analysis of a novel intertypic recombinant human adenovirus causing epidemic keratoconjunctivitis in Japan.

Authors:  Hisatoshi Kaneko; Koki Aoki; Shigeaki Ohno; Hiroaki Ishiko; Tsuguto Fujimoto; Masayuki Kikuchi; Seiya Harada; Gabriel Gonzalez; Kanako O Koyanagi; Hidemi Watanabe; Tatsuo Suzutani
Journal:  J Clin Microbiol       Date:  2010-12-08       Impact factor: 5.948

8.  Clinical features of adenoviral conjunctivitis at the early stage of infection.

Authors:  Koki Aoki; Hisatoshi Kaneko; Nobuyoshi Kitaichi; Takeshi Ohguchi; Yoshitsugu Tagawa; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

9.  Evaluation of multiplex type-specific real-time PCR assays using the LightCycler and joint biological agent identification and diagnostic system platforms for detection and quantitation of adult human respiratory adenoviruses.

Authors:  David Metzgar; Carl Gibbins; N Ryan Hudson; Morris S Jones
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

Review 10.  Mystery eye: Human adenovirus and the enigma of epidemic keratoconjunctivitis.

Authors:  Rahul A Jonas; Lawson Ung; Jaya Rajaiya; James Chodosh
Journal:  Prog Retin Eye Res       Date:  2019-12-28       Impact factor: 21.198
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.